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Background:  Contrast-enhanced ultrasound (CEUS) has been shown to improve diagnostic accuracy in patients undergoing transesophageal echo 
(TEE) prior to cardioversion of atrial fibrillation (AF). However, its impact on patient management has yet to be determined.
Methods:  We retrospectively reviewed 200 consecutive TEE images between 1/2009 and 1/2011 that were performed on patients with the 
diagnosis of AF or atrial flutter in which CEUS (Definity, Optison) was administered. Fourteen of the 200 (7%) studies were deemed technically 
difficult and were included in our analysis and reviewed by 4 independent cardiologists (56 total cases). Thrombus presence, reviewer confidence 
and management decisions were compared before and after contrast.
Results:  In 19 cases, cardioversion was recommended following contrast administration which was not previously recommended (p < 0.0001). 
Reader confidence improved in 35 cases (63%, p< 0.0001). Further diagnostic testing including cardiac magnetic resonance imaging, cardiac 
computed tomography and repeat TEE was avoided in 57% of cases using CEUS. There were no adverse neurologic events in the 14 patients 
included, of which only 1 patient was confirmed to have a left atrial appendage thrombus. A cost-benefit analysis showed a savings using contrast 
($227/patient).
Conclusion: Contrast enhanced TEE changes management and improves reader confidence while providing a reduction in unnecessary diagnostic 
testing, expense and time to cardioversion.
